Evidence map›Paper›PMID 36002660›Full record

ArticleOncogene2022

Correction: TP53, CDKN2A/P16, and NFE2L2/NRF2 regulate the incidence of pure- and combined-small cell lung cancer in mice.

Samera H Hamad, Stephanie A Montgomery, Jeremy M Simon, Brittany M Bowman, Kyle B Spainhower, Ryan M Murphy, Erik S Knudsen, Suzanne E Fenton, Scott H Randell, Jeremiah R Holt and 5 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Oncogene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Samera H HamadLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Stephanie A MontgomeryLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Jeremy M SimonLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Brittany M BowmanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Kyle B SpainhowerDepartment of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT, USA.
Ryan M MurphyDepartment of Pharmacology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Erik S KnudsenRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.ORCID http://orcid.org/0000-0002-5130-5969
Suzanne E FentonDivision of National Toxicology Program, NIEHS/NIH, Research Triangle Park, NC, USA.
Scott H RandellMarsico Lung Institute, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA.
Jeremiah R HoltUniversity of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-5201-5015
D Neil HayesUniversity of Tennessee Health Science Center for Cancer Research, Department of Medicine, Division of Hematology and Oncology, University of Tennessee, Memphis, TN, USA.
Agnieszka K WitkiewiczRoswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Trudy G OliverDepartment of Oncological Sciences, School of Medicine, University of Utah, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0003-2082-2397
M Ben MajorLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. bmajor@wustl.edu.ORCID http://orcid.org/0000-0002-6753-8513
Bernard E WeissmanLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA. weissman@med.unc.edu.ORCID http://orcid.org/0000-0002-1827-2309

Funding

The Role of Protein Kinases in NRF2-driven Lung Squamous Cell CarcinomaR01CA216051 · NCI · WASHINGTON UNIVERSITY · PI MAJOR, MICHAEL BENJAMIN, WEISSMAN, BERNARD E. · 2018 to 2022
$2.5M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36002660

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.